EXHIBIT 10.18.2 AMENDMENT #2 TO THE EXCLUSIVE DISTRIBUTION AGREEMENT THIS AMENDMENT (the "AMENDMENT") is entered into and effective as of the 7th day of March, 2005 (the "AMENDMENT DATE"), by and between Macy's Merchandising Group, LLC ("MMG"), a...The Exclusive Distribution Agreement • May 16th, 2005 • Tarrant Apparel Group • Women's, misses', and juniors outerwear • New York
AMENDMENT NO. 1 TO THE EXCLUSIVE DISTRIBUTION AGREEMENT BY AND BETWEEN DS LABORATORIES, INC. AND EZIO DA FONSECAThe Exclusive Distribution Agreement • December 2nd, 2009 • Divine Skin Inc. • Perfumes, cosmetics & other toilet preparations
This Amendment No. 1 to the Exclusive Distribution Agreement by and between DS Laboratories, Inc. and Ezio da Fonseca made effective as of the 1st day of October 2009 (the “Amendment”) by and between DS Laboratories, Inc. (“Manufacturer”) and Divine Skin, Inc. (“Issuer”) and Ezio da Fonseca (“Distributor”) and amends that certain Exclusive Distribution Agreement by and between DS Laboratories, Inc. and Ezio da Fonseca effective October 1, 2009 (the “Distribution Agreement”).
SECOND AMENDMENT TO THE EXCLUSIVE DISTRIBUTION AGREEMENTThe Exclusive Distribution Agreement • March 24th, 2006 • Halozyme Therapeutics Inc • Biological products, (no disgnostic substances)
This SECOND AMENDMENT TO THE EXCLUSIVE DISTRIBUTION AGREEMENT (this “2nd Amendment”), effective as of December 2, 2005 (the “2nd Amendment Date”), is entered into by and between BAXTER HEALTHCARE CORPORATION with its principal place of business at One Baxter Parkway, Deerfield, Illinois 60015-4633 (“Baxter”), and HALOZYME, INC. with its principal place of business at 11588 Sorrento Valley Road, Suite 17, San Diego, California 92121 (“Halozyme”).
